LCKLSL

Overview

LCKLSL is a N-terminal hexapeptide and a competitive annexin A2 ( AnxA2 ) inhibitor. LCKLSL potently inhibits the binding of tissue plasminogen activator (tPA) to AnxA2 . LCKLSL also inhibits the generation of plasmin and has anti-angiogenic roles.

Application

Products | Products > Peptides | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Cardiovascular Disease | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Annexin A

Product Information

• Catalog No.: HY-P2333
• CAS No.: 533902-29-3
• Molecular Formula: C30H57N7O8S
• Molecular Weight: 675.88
• Purity: 99.26%
• Storage: Sealed storage, away from moisture. Powder -80°C, 2 years , -20°C, 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Availability: In-stock

Source

Original product source